Magnetic Resonance Imaging–Guided Phase 1 Trial of Putaminal AADC Gene Therapy for Parkinson's Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Magnetic Resonance Imaging–Guided Phase 1 Trial of Putaminal
AADC
Gene Therapy for Parkinson's Disease
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-26
DOI
10.1002/ana.25450
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
- (2017) Valerie Voon et al. LANCET NEUROLOGY
- Changes in Quality of Life in Parkinson's Disease: How Large Must They Be to Be Relevant?
- (2017) Krisztina Horváth et al. NEUROEPIDEMIOLOGY
- Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease
- (2017) Yoshihide Sehara et al. Human Gene Therapy Clinical Development
- Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial
- (2017) Agnieszka Ciesielska et al. PLoS One
- Transduction of antigen-presenting cells in the brain by AAV9 warrants caution in preclinical studies
- (2015) John Forsayeth et al. MOLECULAR THERAPY
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
- (2013) Raymond T Bartus et al. MOLECULAR THERAPY
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain
- (2011) R. Mark Richardson et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
- (2010) Lisa M. Shulman et al. ARCHIVES OF NEUROLOGY
- Effects of a Dopamine Agonist on the Pharmacodynamics of Levodopa in Parkinson Disease
- (2010) Matthew A. Brodsky et al. ARCHIVES OF NEUROLOGY
- Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors
- (2010) Xiaomin Su et al. MOLECULAR THERAPY
- Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
- (2010) Piotr Hadaczek et al. MOLECULAR THERAPY
- A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
- (2010) Shin-ichi Muramatsu et al. MOLECULAR THERAPY
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now